Oxford BioMedica warns revenue will be hit by AstraZeneca jab uncertainty
Shares slide as London-listed group announces ‘pause’ in vaccine manufacturing
Full Article
Oxford BioMedica warns revenue will be hit by AstraZeneca jab uncertainty
FT.com
0 shares
1 views